AngioDynamics Inc (STU:UG2)
€ 11.8 -0.40 (-3.28%) Market Cap: 490.34 Mil Enterprise Value: 455.43 Mil PE Ratio: 0 PB Ratio: 3.30 GF Score: 66/100

AngioDynamics Inc at Goldman Sachs Healthcare Conference Transcript

Jun 10, 2026 / 01:20PM GMT
Release Date Price: €10.6
James Clemmer
AngioDynamics Inc - President, Chief Executive Officer, Director

Hi. Welcome. Welcome to the AngioDynamics Goldman Sachs Investor Conference Presentation. My name is Jim Clemmer. I'm the CEO of AngioDynamics, and thank you for joining us today.

We'll start by reminding all investors to do your homework. What we'll say and present today are our projections, our thoughts, our strategies, and our ideas about our business and the markets we serve. We'll do our best to be accurate in the information we put forth, but do the best you can as investors to do your research before you make any investments.

So let's talk about AngioDynamics. So AngioDynamics is a company founded in 1988, but really live two different lives. Over the past six years or so, we've taken this company to a new level. So if you look at us pre-2020, pre our transformation, you'll see a very different company. It was a company built to serve the Interventional Radiologist as our primary call point, and we did a really good job.

We're known for quality products, and we are a good partner for those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot